AbbVie Inc. (NYSE:ABBV)

Prescription drugs

Short Sellers Run For Cover From Major Pharma

The short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Money background. Close-up.

Are AbbVie Earnings Enough?

AbbVie Inc. (NYSE: ABBV) reported its second-quarter financial results Friday before the markets opened. The pharmaceutical giant had $1.08 in earnings per share (EPS) on $5.48 billion in revenue. That ...
Read Full Story »
generic drugs

What to Expect From AbbVie Earnings

AbbVie Inc. (NYSE: ABBV) is scheduled to report its second-quarter financial results before the markets open Friday. The consensus estimates from Thomson Reuters call for $1.06 in earnings per share ...
Read Full Story »
biotech

Top Health Care Earnings for the Week Ahead

Earnings season is hitting its stride next week, and we have taken a look at companies in a variety of sectors that will be posting results next week. The health ...
Read Full Story »
Eli Lilly Logo

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

While it appears at least for the time being that the Greek can once again has been kicked down the road, looking for solid more defensive stocks still makes good ...
Read Full Story »
Pills

Short Sellers Run for Cover in Big Pharma

The short interest data have been released for the June 30 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Pfizer logo

3 UBS Must-Own Large-Cap Pharmaceutical Stocks

Anytime you see warning clouds hovering over the stock market like we may be seeing now, there are two really good options. Sell stocks and raise cash to take advantage ...
Read Full Story »
Pills

Is Big Pharma Advertising Getting Out of Control?

How much are big pharmaceutical companies really spending to get their drugs out there in the public eye? In 2014, these companies spent about $4.5 billion in advertising alone, notably ...
Read Full Story »
Pills

Short Sellers Become More Focused on Big Pharma

The short interest data has been released for the June 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
GoogleLogo

Jefferies Franchise Stock Picks Crush S&P 500: 4 to Buy Now

The rage for the past 10 to 15 years has been to index. Stock picking, once the trademark of such great managers as Peter Lynch and Bill Miller, was pushed ...
Read Full Story »
Prescription drugs

Short Sellers Back Off Big Pharma

The short interest data has been released for the May 29 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
PBR-logo

The 6 Most Shorted NYSE Stocks in May

AT&T continued to reign as the most shorted stock trading on the New York Stock Exchange between the May 15 and May 29 settlement dates. In addition, after shying away ...
Read Full Story »
Prescription drugs

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

Credit Suisse sees some solid upside in big pharma in the coming years. After the health care sector has made a strong run, this firm believes that it can continue, ...
Read Full Story »
health care

How Halozyme Will Continue to Grow With Its New Deal

The roar from the health care sector has been loud and long. It was built on the innovations of many firms releasing positive results from their clinical trials, as well ...
Read Full Story »
generic drugs

The 4 Overlooked Winners of ASCO

The American Society of Clinical Oncology’s (ASCO) annual meeting is coming to a close. Companies and cancer drug developers across the health care sector flock to this conference to share ...
Read Full Story »